Literature DB >> 23960567

Pacing for hypertrophic obstructive cardiomyopathy does it work?

Q Zaidi1, H Zaky, O Aljassim.   

Abstract

Sixty-nine years old lady presented with sudden cardiac arrest, she was found to have hypertrophic obstructive cardiomyopathy, she refused septal myomectomy and had a dual chamber ICD implanted, she was put on right ventricular apical pacing with short AV interval, after pacing her max pressure gradient across left ventricular out flow tract (LVOT) dropped from 117 mmHg to 21 mmHg and her symptoms much improved over a follow up period of 1 year.

Entities:  

Year:  2009        PMID： 23960567      PMCID： PMC3727354          DOI： 10.1016/j.jsha.2009.06.006

Source DB:  PubMed          Journal:  J Saudi Heart Assoc        ISSN： 1016-7315


  10 in total

Review 1.  Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death.

Authors:  William J McKenna; Elijah R Behr
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

2.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).

Authors:  Gabriel Gregoratos; Jonathan Abrams; Andrew E Epstein; Roger A Freedman; David L Hayes; Mark A Hlatky; Richard E Kerber; Gerald V Naccarelli; Mark H Schoenfeld; Michael J Silka; Stephen L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; Gabriel Gregoratos; Loren F Hiratzka; David P Faxon; Alice K Jacobs; Valentin Fuster; Sidney C Smith
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

3.  Mitral valve replacement for idiopathic hypertrophic subaortic stenosis. Results in 27 patients.

Authors:  D A Cooley; D C Wukasch; R D Leachman
Journal:  J Cardiovasc Surg (Torino)       Date:  1976 Sep-Oct       Impact factor: 1.888

4.  Current operative treatment of obstructive hypertrophic cardiomyopathy.

Authors:  C L McIntosh; B J Maron
Journal:  Circulation       Date:  1988-09       Impact factor: 29.690

5.  Long-term medical management of hypertrophic obstructive cardiomyopathy.

Authors:  M J Frank; A M Abdulla; M I Canedo; R E Saylors
Journal:  Am J Cardiol       Date:  1978-12       Impact factor: 2.778

6.  Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.

Authors:  L Fananapazir; R O Cannon; D Tripodi; J A Panza
Journal:  Circulation       Date:  1992-06       Impact factor: 29.690

7.  Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.

Authors:  R O Bonow; D R Rosing; S L Bacharach; M V Green; K M Kent; L C Lipson; B J Maron; M B Leon; S E Epstein
Journal:  Circulation       Date:  1981-10       Impact factor: 29.690

8.  Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features.

Authors:  W McKenna; J Deanfield; A Faruqui; D England; C Oakley; J Goodwin
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778

9.  Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy.

Authors:  K McDonald; E McWilliams; B O'Keeffe; B Maurer
Journal:  Eur Heart J       Date:  1988-08       Impact factor: 29.983

10.  Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy.

Authors:  X Jeanrenaud; J J Goy; L Kappenberger
Journal:  Lancet       Date:  1992-05-30       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.